Literature DB >> 24186672

Options for managing severe acetabular bone loss in revision hip arthroplasty. A systematic review.

Sameer Jain1, Richard J Grogan, Peter V Giannoudis.   

Abstract

Revision hip arthroplasty in the presence of severe acetabular bone loss is challenging and requires a solid understanding of current techniques. A literature search of multiple databases applying specific criteria revealed a total of 50 articles of level IV scientific evidence comprising 2415 patients (2480 hips) managed with reinforcement devices (roof-reinforcement rings and anti-protrusio cages), custom-made triflanged acetabular components (CTACs), jumbo cups and tantalum metal (TM) systems. Overall, patients had improved postoperative hip scores for each technique. The use of reinforcement devices resulted in a mean revision rate of 8.2% and a mean complication rate of 29.21%. CTACs were associated with a revision rate of 15.9% and had a complication rate of 24.5%. Jumbo cups were revised in 8.8% of patients and had a complication rate of 18.4%. TM systems had an overall revision rate of 8.5% with complications seen in 18.5% of patients. CTACs had considerably higher revision rates compared to the other techniques. Jumbo cups and TM systems had lower complication rates compared to the use of reinforcement devices and CTACs. The most frequently occurring complications seen throughout the series were aseptic loosening, dislocation and infection.

Entities:  

Mesh:

Year:  2013        PMID: 24186672     DOI: 10.5301/hipint.5000101

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  9 in total

1.  Acetabular Defect Reconstruction with Trabecular Metal Augments: Study with Minimum One-year Follow-up.

Authors:  Chirayu Dwivedi; Sandeep Gokhale; Hyun Gon Khim; Jeon Keon Oh; Won Yong Shon
Journal:  Hip Pelvis       Date:  2017-09-06

2.  Acetabular revision arthroplasty using trabecular titanium implants.

Authors:  Boris Steno; Milan Kokavec; Libor Necas
Journal:  Int Orthop       Date:  2014-09-06       Impact factor: 3.075

Review 3.  Treatment options for chronic pelvic discontinuity.

Authors:  Mark D Hasenauer; Wayne G Paprosky; Neil P Sheth
Journal:  J Clin Orthop Trauma       Date:  2017-09-18

Review 4.  Acetabular reconstruction in revision total hip arthroplasty.

Authors:  George W Fryhofer; Sireesh Ramesh; Neil P Sheth
Journal:  J Clin Orthop Trauma       Date:  2019-12-02

5.  Minimum 2-Year Outcomes of a Novel 3D-printed Fully Porous Titanium Acetabular Shell in Revision Total Hip Arthroplasty.

Authors:  Elyse J Berlinberg; J Abraham Kavian; Mackenzie A Roof; Ittai Shichman; Brett Frykberg; William B Lutes; Erik A Schnaser; Stephen A Jones; Richard W McCalden; Ran Schwarzkopf
Journal:  Arthroplast Today       Date:  2022-10-12

6.  Use of Customized 3D-Printed Titanium Augment With Tantalum Trabecular Cup for Large Acetabular Bone Defects in Revision Total Hip Arthroplasty: A Midterm Follow-Up Study.

Authors:  Keyu Kong; Chen Zhao; Yongyun Chang; Hua Qiao; Yi Hu; Huiwu Li; Jingwei Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-01

7.  Tritanium acetabular wedge augments: short-term results.

Authors:  Camilo Restrepo; Snir Heller; Antonia F Chen
Journal:  Ann Transl Med       Date:  2016-06

8.  Outcome and EBRA migration analysis of a reconstruction cage in acetabular revision arthroplasty: a clinical and radiological study.

Authors:  Dietmar Dammerer; Philipp Blum; David Putzer; Annelies van Beeck; Michael Nogler; Martin Thaler
Journal:  Arch Orthop Trauma Surg       Date:  2020-12-22       Impact factor: 3.067

Review 9.  The Diagnosis and Treatment of Acetabular Bone Loss in Revision Hip Arthroplasty: An International Consensus Symposium.

Authors:  Peter K Sculco; Timothy Wright; Michael-Alexander Malahias; Alexander Gu; Mathias Bostrom; Fares Haddad; Seth Jerabek; Michael Bolognesi; Thomas Fehring; Alejandro Gonzalez DellaValle; William Jiranek; William Walter; Wayne Paprosky; Donald Garbuz; Thomas Sculco
Journal:  HSS J       Date:  2021-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.